Close Menu

Trovagene

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Trovagene today said it has completed its acquisition of the CLIA laboratory of MultiGen Diagnostics.

TrovaGene said this week that it has obtained an exclusive worldwide license for mutations of the SF3B1 splicing factor that are associated with disease progression and chemotherapy response in chronic lymphocytic leukemia.

PrimeraDx this week announced that it has appointed Leroy Hood to its scientific advisory board.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – TrovaGene today said that it has licensed exclusive worldwide rights to assay technology for the detection of hairy cell leukemia.

By Monica Heger
This story, originally published Aug. 11, has been updated to include comments from TrovaGene co-founder Gabriele Cerrone.

Canon, Philipps-Universität Marburg, Johns Hopkins University, Brandeis University, Samsung, City of Hope, Amplion, and Trovagene are awarded US patents.

US patents awarded to LLNL, TrovaGene, Rockefeller U, Gen-Probe, Human Genetic Signatures, Riken, DNAForm, U of Utah, Idaho Tech, Rubicon, Cepheid, Toshiba, Chang Gung University, Samsung, Apodemus, and Robert-Koch Institut.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.